Failure of mobilization of hematopoietic stem cells associated with elevated serum levels of anti-CD38 monoclonal antibody

被引：7
|
作者：
Seth, Abhishek [1 ]
Murray, David [2 ]
Buadi, Francis K. [1 ]
Gertz, Morie A. [1 ]
Yadav, Udit [1 ]
Kumar, Shaji K. [1 ]
Gonsalves, Wilson I. [1 ]
机构：
[1] Mayo Clin, Dept Hematol, 200 First St SW, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA
来源：
EUROPEAN JOURNAL OF HAEMATOLOGY | 2023年 / 111卷 / 02期
基金：
美国国家卫生研究院;
关键词：
daratumumab; impaired mobilization; mass-spectrometry; multiple myeloma; MULTIPLE-MYELOMA;
D O I：
10.1111/ejh.14008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Daratumumab is an anti-CD38 antibody that is increasingly incorporated in induction regimens for treating patients with newly diagnosed multiple myeloma (NDMM). Previous reports have demonstrated a lower yield of hematopoietic stem cells (HSCs) after induction with daratumumab; however, none of them reported a failure to collect an adequate number of HSCs. We describe a case of adequate HSC mobilization failure in a patient who inadvertently received excessive doses of daratumumab and was confirmed by higher-than-expected circulating levels of daratumumab by mass spectrometry. Eventual clearance of circulating daratumumab was associated with the successful mobilization and harvesting of HSCs.
引用
收藏
页码：318 / 321
页数：4
相关论文
共 50 条
  • [1] Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients-A Systematic Review
    Bigi, Flavia
    Manzato, Enrica
    Barbato, Simona
    Talarico, Marco
    Puppi, Michele
    Masci, Simone
    Sacchetti, Ilaria
    Restuccia, Roberta
    Iezza, Miriam
    Rizzello, Ilaria
    Sartor, Chiara
    Mancuso, Katia
    Pantani, Lucia
    Tacchetti, Paola
    Cavo, Michele
    Zamagni, Elena
    PHARMACEUTICALS, 2024, 17 (07)
  • [2] A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia
    Chen, Yunfei
    Xu, Yanmei
    Li, Huiyuan
    Sun, Ting
    Cao, Xuan
    Wang, Yuhua
    Xue, Feng
    Liu, Wei
    Liu, Xiaofan
    Dong, Huan
    Fu, Rongfeng
    Dai, Xinyue
    Wang, Wentian
    Ma, Yueshen
    Song, Zhen
    Chi, Ying
    Ju, Mankai
    Gu, Wenjing
    Pei, Xiaolei
    Yang, Renchi
    Zhang, Lei
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (23): : 2178 - 2190
  • [3] DARATUMUMAB Anti-CD38 Monoclonal Antibody, Treatment of Multiple Myeloma
    Richardson, P.
    Lokhorst, H.
    Palumbo, A.
    Nahi, H.
    Laubach, J.
    Gimsing, P.
    Lisby, S.
    Cakana, A.
    Brun, N. Constantin
    Plesner, T.
    DRUGS OF THE FUTURE, 2013, 38 (08) : 545 - 554
  • [4] Transfusion management for patients taking an anti-CD38 monoclonal antibody
    Bub, Carolina Bonet
    dos Reis, Isabel Nagle
    Aravechia, Maria Giselda
    Santos, Leandro Dinalli
    Bastos, Eduardo Peres
    Kutner, Jose Mauro
    Castilho, Lilian
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2018, 40 (01) : 25 - 29
  • [5] Anti-CD38 monoclonal antibody impairs CD34+mobilization and affects clonogenic potential in multiple myeloma patients
    Zappaterra, Arianna
    Civettini, Ivan
    Cafro, Anna Maria
    Pezzetti, Laura
    Pierini, Silvia
    Anghilieri, Michela
    Bellio, Laura
    Bertazzoni, Paola
    Grillo, Giovanni
    Minga, Periana
    Pioltelli, Maria L.
    Ravano, Emanuele
    Sassone, Marianna
    V. Vigano, Clara
    Volpato, Elisabetta B.
    Gambacorti-Passerini, Carlo
    Rossini, Silvano
    Cairoli, Roberto
    Crocchiolo, Roberto
    BLOOD TRANSFUSION, 2024, 22 (04) : 328 - 337
  • [6] Therapeutic Anti-CD38 Monoclonal Antibody as a Cause of Panreactive Antibody Screening in Immunohematology
    Luzzi, J.
    Brito, C. A.
    Gimenez, N. T.
    Navarro-Xavier, R. A.
    Jesuino, D. B.
    TRANSFUSION, 2016, 56 : 139A - 139A
  • [7] The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma
    Moreno, Laura
    Perez, Cristina
    Zabaleta, Aintzane
    Manrique, Irene
    Alignani, Diego
    Ajona, Daniel
    Blanco, Laura
    Lasa, Marta
    Maiso, Patricia
    Rodriguez, Idoia
    Garate, Sonia
    Jelinek, Tomas
    Segura, Victor
    Moreno, Cristina
    Merino, Juana
    Rodriguez-Otero, Paula
    Panizo, Carlos
    Prosper, Felipe
    San-Miguel, Jesus F.
    Paiva, Bruno
    CLINICAL CANCER RESEARCH, 2019, 25 (10) : 3176 - 3187
  • [8] Serum proteins with NAD+ glycohydrolase activity and anti-CD38 reactivity -: elevated levels in serum of tumour patients
    Korkut, Ç
    Yalçintepe, L
    Kiremit-Korkut, N
    Uzun-Altinöz, S
    Issever, S
    Gümüsel, F
    Tiryaki, D
    Bermek, E
    CANCER LETTERS, 1998, 126 (01) : 105 - 109
  • [9] Anti-CD38 Monoclonal Antibody Is a Salvage Regimen in Relapsed/Refractory Aplastic Anemia
    Li, Weiwang
    Zhang, Lele
    Pan, Hong
    Gao, Zhen
    Li, Jianping
    Nie, Neng
    Zhao, Xin
    Huang, Jinbo
    Zhao, Jingyu
    Yu, Xiao
    Kuang, Zhexiang
    Fang, Liwei
    Ge, Meili
    Yuan, Weiping
    Shi, Jun
    BLOOD, 2024, 144 : 2697 - 2697
  • [10] The Anti-CD38 Monoclonal Antibody TAK-079 Depletes Antibody Secreting Cells from Normal and SLE Patients
    Wang, Xiaoqian
    Dahl, Martin
    Nguyen, Doan
    Jenks, Scott
    Cashman, Kevin
    Lee, F. Eun-Hyung
    McLean, Lachy
    Sanz, Ignacio
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345